Starling Oncology, Inc. Warrant
STLNW
13 hedge funds and large institutions have $2.77M invested in Starling Oncology, Inc. Warrant in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
8% more funds holding
Funds holding: 12 → 13 (+1)
0.81% more ownership
Funds ownership: 4.79% → 5.6% (+0.81%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
62% less capital invested
Capital invested by funds: $7.36M → $2.77M (-$4.59M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$116K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$85.8K |
| 3 |
CAC
Cowen and Company
New York
|
+$39.2K |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
USPCM
Union Square Park Capital Management
New York
|
-$66K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$3.28K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LP
1
LMR Partners
London,
United Kingdom
| $2.42M | +$85.8K | +262,954 | +22% |
|
|
DM
2
Deerfield Management
New York
| $138K | – | – | – |
|
|
HCM
3
Highbridge Capital Management
New York
| $62K | – | – | – |
|
|
4
Walleye Capital
New York
| $39.1K | +$116K | +355,410 | New |
|
|
DKCM
5
Davidson Kempner Capital Management
New York
| $35K | – | – | – |
|
|
CAC
6
Cowen and Company
New York
| $13.2K | +$39.2K | +120,100 | New |
|
|
DCM
7
Difesa Capital Management
New York
| $12.8K | – | – | – |
|
|
JFG
8
Jefferies Financial Group
New York
| $10.5K | +$31K | +95,000 | New |
|
9
Man Group
London,
United Kingdom
| $10.4K | – | – | – |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| $10.3K | -$3.28K | -10,058 | -10% |
|
11
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
| $9.63K | – | – | – |
|
|
AGM
12
Alpine Global Management
New York
| $3K | – | – | – |
|
|
TCM
13
Tenor Capital Management
New York
| $2.75K | – | – | – |
|
|
14
UBS Group
Zurich,
Switzerland
| $67 | -$1.59K | -4,889 | -89% |
|
|
USPCM
15
Union Square Park Capital Management
New York
| – | -$66K | -120,000 | Closed |
|
STLNW Hedge Fund Activity: Q4 2022 in Review
13 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q4 2022, worth a combined $2.77M — down 62% from $7.36M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new STLNW positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Walleye Capital, opening a new position worth an estimated $116K. The largest seller was Union Square Park Capital Management, exiting entirely with an estimated $66K sold.
- 13 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q4 2022, up from 12 in Q3 2022.
- Funds reported $2.77M of Starling Oncology, Inc. Warrant stock for Q4 2022, down 62% quarter-over-quarter.
- 3 funds opened new Starling Oncology, Inc. Warrant positions in Q4 2022 and 1 closed out, a net change of +2 holders.
- The largest Starling Oncology, Inc. Warrant buyer in Q4 2022 was Walleye Capital, an estimated $116K added.
- The largest Starling Oncology, Inc. Warrant seller in Q4 2022 was Union Square Park Capital Management, an estimated $66K sold.
Based on aggregated 13F filings for Q4 2022.